Subscribe
Subscribe

Industrial application, Technology and digital innovation

Betting on the best egg: Aurora test doubles pregnancy chances in assisted conception

Assisted conception techniques have matured in the last few decades, with Belgian scientists playing a big part in the progress. The Aurora test, developed by the Belgian start-up Fertiga, now further improves the odds for couples wanting to be parents: the test doubles the chances of becoming pregnant after just one fertility treatment.

Spectricity Raises €14 Million Series B Funding as it Accelerates Plans to Deliver Industry Leading Hyperspectral Sensing to Mobile and Consumer Devices

Funding Expands Growth for Tiny Chip-size Sensors for Unimaginable New Applications.

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

Azalea Vision closes € 8 million Series A to develop a smart contact lens for light sensitivity and ocular disorders

Azalea Vision develops autonomous smart solutions embedded inside a contact lens to improve the quality of life of people with light sensitivity or ocular disorders. The company has announced the closing of its Series A funding round, comprised of € 6.2 million in equity and € 1.8 million as a non-dilutive grant.

Newton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology

Moderna: from secretive platform company to vaccine superstar

Moderna Therapeutics has never really been a typical biotech. Sure, nowadays it is world famous thanks to its COVID-19 vaccine, which has resulted in an $80 billion market cap and projected sales of $18.4 billion for 2021. But the path to success has not been that of a standard biotech’s journey. Through ups and downs, controversies and triumphs, here’s the fascinating story behind the rise of Moderna and the creation of its COVID-19 vaccine.

Friend or foe: building a healthy relationship with your board

CEOs of start-ups face many challenges. Among many tasks, they have to set up the organization, write the business plan, build an effective management team and, of course, attract finance. How concerned should they be with the composition of the board? And what can CEOs do to ensure that the board helps rather than hinders their company?

Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy

Montis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics

Trusting gut bacteria: MRM Health develops microbiome treatments for IBD and more

In the last decade, there has been a growing interest in the potential of microbiome-based therapeutics: using gut bacteria as a medication to battle a wide array of diseases. Ghent-based start-up MRM Health is an important innovator in this growing field, building on the expertise of sister company ProDigest and of prominent partners such as VIB and DuPont Nutrition Biosciences. In the coming months, MRM Health is starting clinical trials for a drug candidate for ulcerative colitis, a type of inflammatory bowel disease (IBD).

Ground-breaking Flemish health projects go virtual: Smart Hub Flemish Brabant launches Health Experience

Smart Hub Flemish Brabant has launched the innovative online platform ‘Health Experience’. The virtual tour gives exclusive insights into the ground-breaking projects of Materialise, imec, Health House, Rega Institute KU Leuven, Brussels Airport and B-PHOT Brussels Photonics.

Pulsify Medical closes second round Series A funding of EUR 6.35 million for wearable ultrasound heart monitor patch

Leuven, Belgium, 4 May 2021 - Pulsify Medical is a digital medical technology company developing wearable ultrasound patches which will monitor vital organs in real-time. The new and disruptive technology will address a serious unmet need for continuous cardiac monitoring in ICUs, hospitals, and homes across the world

Belgian pharma industry among the EU’s strongest despite pandemic setbacks

How did the Belgian chemical and pharmaceutical sector fare during the first year of the pandemic? A report from essenscia gives insight into the financial downturn caused by the global crisis in 2020, but also showed strong positive trends in job creation and innovation. There were record investments in research and development, particularly in the healthcare sector, which continues to score among the best in Europe.

Antwerp start-up to convert CO2 into industry building blocks

The University of Antwerp spin-off D-CRBN is helping carbon-emitting industries transform greenhouse gases into useful products. Using plasma technology, the company can split harmful CO2 molecules into their basic building blocks, which can then be converted into biofuels and polymers. The company aims to contribute to the circular economy needed if the European Green Deal is to be a success.

Proteomics PharmaFluidics Launches Next Generation µPAC™ Technology for Routine Proteomics

Microfluidic chips for use in high-resolution nanoLC/MS workflows Ghent, Belgium, 27 April 2021 - PharmaFluidics NV, innovative life sciences instruments player, is excited to announce a step change in its product offering, extending the range with its next generation µPAC™ nano-LC chips, preferred workhorses for routine proteomics. The news was revealed at a broadly attended user-community meeting held on Friday, April 23rd.